U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Development Considerations of Antifungal Drugs to Address Unmet Medical Need - 08/04/2020 - 08/04/2020
  1. FDA Meetings, Conferences and Workshops

Workshop

Event Title
Development Considerations of Antifungal Drugs to Address Unmet Medical Need
August 4, 2020


Date:
August 4, 2020
Time:
9:00 AM - 5:00 PM ET

DESCRIPTION/SUMMARY

This public workshop is currently being scheduled and planned as a virtual meeting. The Food and Drug Administration is announcing a virtual public workshop to discuss unmet medical needs of invasive molds and Candida auris and clinical trial design considerations for developing new therapies.

ABOUT THE PUBLIC WORKSHOP

FDA is announcing a virtual public workshop regarding the development of new therapies to address unmet medical need for the treatment of infections due to invasive molds and Candida auris. Discussions will focus on the current state and clinical trial design considerations for developing new therapies for these infections and include the following topic areas:

  • Clinical need for new antifungal drugs to address unmet medical need
  • Trial design considerations, including trial populations, endpoints, and control arm for difficult to treat invasive mold infections and Candida auris infections

REGISTRATION

This meeting will be held in virtual format only. Registration is required for online attendance and will be available until 5:00 pm on August 2, 2020.

To register for this workshop, visit https://www.eventbrite.com/e/antifungal-drugs-to-address-unmet-medical-needs-public-workshop-tickets-95257211885

REQUEST FOR ORAL PRESENTATIONS

During online registration you may indicate if you wish to present during a public comment session, and which topic(s) you wish to address. We will do our best to accommodate requests to make public comments. We will determine the amount of time allotted to each presenter and the approximate time each oral presentation is to begin and will select and notify participants by July 21, 2020. All requests to make oral presentations must be received by July 14, 2020. If selected for presentation, any presentation materials must be emailed to ONDPublicMTGSupport@fda.hhs.gov no later than July 28, 2020.

MEETING MATERIALS

All other meeting materials, including speaker slides and transcripts, will be available here before and after the workshop. Please visit this page for any updates.

ONLINE ATTENDANCE (WEBCAST)

This meeting will be available for online viewing, on the day of the meeting via the following link: https://collaboration.fda.gov/antifungaldrugs080420/

If you have never attended a Connect Pro event before, test your connection at https://collaboration.fda.gov/common/help/en/support/meeting_test.htm.

To get a quick overview of the Connect Pro program, visit https://www.adobe.com/go/connectpro_overview.

EVENT POINT OF CONTACT

Antoinette Ziolkowski, at Antoinette.Ziolkowski@fda.hhs.gov. Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, rm. 6221, Silver Spring, MD 20993-0002, 301-796-1300.

Back to Top